Brain Cancer News and Research

RSS

There are two main types of brain cancer. Primary brain cancer starts in the brain. Metastatic brain cancer starts somewhere else in the body and moves to the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Also called glioma, meningioma.

Combination of two types of radiation therapy is better for treating brain cancer

Adding stereotactic radiosurgery – which entails delivering radiation to specific points in the brain while sparing normal tissue – after whole brain radiation therapy helps certain patients with cancer that has spread to the brain live longer, says a new study by researchers at Thomas Jefferson University Hospital in Philadelphia.

25 May 2004

People in Michigan with low incomes may be more likely to develop brain cancer

The study, which looked at more than 1,000 cases of people with brain cancer during a two-year period (1996-1997), was published in the recent edition of Neurology, the scientific journal of the American Academy of Neurology.

25 May 2004

People with low incomes are more likely to develop brain cancer

People with low incomes are more likely to develop brain cancer, according to a study published in the May 25 issue of Neurology, the scientific journal of the American Academy of Neurology.

24 May 2004

Combination radiation treatment for brain cancer leads to better life

People with cancer that has spread to the brain – about 40 percent of all cancer cases – live longer and enjoy a better quality of life if they are treated with a combination of radiation techniques, according to research conducted, in part, at the James P. Wilmot Cancer Center at the University of Rochester Medical Center.

21 May 2004

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

The Cleveland Clinic has been awarded a four-year, $1.4 million grant from the National Institutes of Health to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier. Researchers hope to use their findings to develop new methods to limit the damage caused by such events.

17 May 2004

World's first gene therapy trial aimed at preventing cancer

The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep cell growth in check, or would flush the body with "super genes" that could attack and destroy cancer.

5 May 2004

Researchers find new purpose for existing drugs to suppress colon cancer metastasis, secure post-radiation brain function, and trick tumors

Drugs approved for treatment of specific maladies sometimes show unexpected benefits. Researchers at the 95th annual meeting of the American Association for Cancer Research demonstrated highlighted how some drugs may one day offer previously unforeseen benefits for patients.

30 Mar 2004

New Research Information on Tumor Necrosis Therapy

Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute’s Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People’s Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.

25 Mar 2004